Twist Bioscience Corporation
TWST
Key stats
- Open
- 99.72
- Day high
- 114.97
- Day low
- 93.68
- Previous close
- 122.59
- Volume
- 5.29M
- VWAP
- 109.38
- 52-week high
- 219.71
- 52-week low
- 23.30
- Market cap
- 8.13B
- Shares out
- 62.71M
- Employees
- 979
- Listed
- 2018
About Twist Bioscience Corporation
Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) · SOUTH SAN FRANCISCO, CA · twistbioscience.com
Options · expiring Nov 20
Nov 12, 4:00 PM ET- Call open interest
- 783
- Put open interest
- 3.8K
- Put/call
- 4.88
- At-the-money IV
- 117.5%
| Contract | Last | Traded | Volume | Open int. | IV |
|---|---|---|---|---|---|
| 120 put | 11.60 | Nov 12, 2:49 PM | 141 | 532 | 100.4% |
| 120 call | 4.20 | Nov 12, 1:20 PM | 113 | 110 | 117.1% |
| 130 call | 1.75 | Nov 12, 12:26 PM | 107 | 70 | 113.6% |
| 115 call | 6.50 | Nov 12, 3:32 PM | 100 | 206 | 117.5% |
| 95 call | 10.50 | Nov 12, 9:45 AM | 86 | 0 | 140.4% |
| 110 put | 6.00 | Nov 12, 1:01 PM | 83 | 357 | 105.8% |
Quarterly results
Massive · Aug 3, 2026| Q3 2026 to Jun 30, 2026 | Q2 2026 to Mar 31, 2026 | Q1 2026 to Dec 31, 2025 | Q4 2025 to Sep 30, 2025 | |
|---|---|---|---|---|
| Revenue | $118.38M | $110.72M | $103.70M | $99.01M |
| Gross profit | $62.45M | $57.12M | $53.97M | $50.84M |
| Operating income | −$36.28M | −$45.86M | −$32.90M | −$29.93M |
| Net income | −$35.05M | −$44.02M | −$30.51M | −$27.14M |
| Diluted EPS | -0.56 | -0.71 | -0.50 | -0.46 |
| Operating cash flow | $1.11M | −$17.56M | −$24.81M | −$11.81M |
| Assets | $672.44M | $676.21M | $638.09M | $641.86M |
| Liabilities | $226.70M | $221.12M | $181.99M | $168.90M |
| Equity | $445.74M | $455.09M | $456.10M | $472.96M |
Technicals
Massive · Nov 12, 2026- 50-day average150.57
- 200-day average92.89
- RSI (14 days)38.7
Short interest
Massive · Oct 30, 2026- Oct 30, 20269.84M shares · 4.3 days to cover
- Oct 15, 202610.21M shares · 2.8 days to cover
- Sep 30, 202610.57M shares · 3.8 days to cover
- Sep 15, 202612.51M shares · 8.9 days to cover
Related companies
MassiveNews coverage
No stories about Twist Bioscience Corporation right now.